Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival

Histopathology

Volumn 59, Issue 6, 2011, Pages 1163-1172

  Zhao, Fung ^a   Siu, Michelle K Y ^a   Jiang, Lili ^a   Tam, Kar Fai ^a   Ngan, Hextan Y S ^a   Le, Xiao Feng ^b   Wong, Oscar G W ^a   Wong, Esther S Y ^a   Chan, Hoi Yan ^a   Cheung, Annie N Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Dock180 expression; Metastasis; Ovarian cancer; Prognostic factor

Indexed keywords

DEDICATOR OF CYTOKINESIS I PROTEIN; GELATINASE A; MESSENGER RNA; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL MIGRATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYSTADENOMA; CYTOPLASM; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; OVARY CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA; CELL MOVEMENT; CYSTADENOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PHENOTYPE; PROGNOSIS; RAC GTP-BINDING PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 84855926182     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.04045.x     Document Type: Article

References (26)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics 2003. CA Cancer J. Clin. 2003; 53; 5-26.
2. Burger RA. A new model of ovarian carcinogenesis may influence early detection strategies. Am. J. Obstet. Gynecol. 2008; 198; 349-350.
3. Sheehan KM, Calvert VS, Kay EW et al. Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol. Cell Proteomics 2005; 4; 346-355.
4. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002; 420; 629-635.
5. Lu M, Ravichandran KS. Dock180-ELMO Cooperation in Rac Activation. Meth. Enzymol. 2006; 406; 388-402.
6. Jean-Francois C, Kristiina V. GEF what? Dock180 and related proteins help Rac to polarize cells in new ways Trends Cell Biol. 2007; 17; 383-393.
7. Brugnera E, Haney L, Grimsley C et al. Unconventional Rac-GEF activity is mediated through the Dock180 ELMO complex. Nat. Cell Biol. 2002; 4; 574-582.
8. Makino Y, Tsuda M, Ichihara S et al. Elmo1 inhibits ubiquitylation of Dock180. J. Cell. Sci. 2006; 119; 923-932.
9. Jarzynka MJ, Hu B, Hui KM et al. ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion. Cancer Res. 2007; 67; 7203-7211.
10. Smith HW, Marra P, Marshall CJ. uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180J. Cell. Biol. 2008; 182; 777-790.
11. Siu MK, Wong ES, Chan HY et al. Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion. Int. J. Cancer 2010; 127; 21-31.
12. Siu MK, Chan HY, Kong DS et al. Pak4 regulates ovarian cancer cell proliferation, migration and invasion and contributes to poor prognosis in patients. Proc. Natl Acad. Sci. USA 2010; 107; 18622-18627.
13. Chan QK, Ngan HY, Ip PP, Liu VW, Xue WC, Cheung AN. Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis - a differential and functional analysis. Carcinogenesis 2009; 20; 114-121.
14. Siu MK, Wong ES, Chan HY, Ngan HY, Chan KY, Cheung AN. Overexpression of NANOG in gestational trophoblastic diseases: effect of apoptosis, cell invasion, and clinical outcome. Am. J. Pathol. 2009; 173; 1165-1172.
15. Janowska-Wieczorek A, Marquez LA, Nabholtz JM et al. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane. Blood 1999; 93; 3379-3390.
16. Wang H, Linghu H, Wang J et al. The role of Crk/Dock180/Rac1 pathway in the malignant behavior of human ovarian cancer cell SKOV-3. Tumor Biol. 2010; 31; 59-67.
17. Wu YC, Horvitz HR. C. elegans phagocytosis and cell-migration protein CED-5 is similar to human DOCK180. Nature 1998; 392; 501-504.
18. Gumienny TL, Brugnera E, Tosello-Trampont AC et al. CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell 2001; 107; 27-41.
19. Erickson MR, Galletta BJ, Abmayr SM. Drosophila myoblast city encodes a conserved protein that is essential for myoblast fusion, dorsal closure, and cytoskeletal organization. J. Cell Biol. 1997; 138; 589-603.
20. Grimsley CM, Kinchen JM, Tosello-Trampont AC et al. Dock180 and ELMO1 proteins cooperate to promote evolutionarily conserved Rac-dependent cell migration. J. Biol. Chem. 2004; 279; 6087-6097.
21. Kenny HA, Lengyel E. MMP-2 functions as an early response protein in ovarian cancer metastasis. Cell Cycle 2009; 8; 683-688.
22. Schmalfeldt B, Prechtel D, Harting K et al. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin. Cancer Res. 2001; 7; 2396-2404.
23. Hasegawa H, Kiyokawa E, Tanaka S et al. DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane. Mol. Cell. Biol. 1996; 16; 1770-1776.
24. Yin J, Haney L, Walk S, Zhou S, Ravichandran KS, Wang W. Nuclear localization of the DOCK180/ELMO complex. Arch. Biochem. Biophys. 2004; 429; 23-29.
25. Kar B, Reichman CT, Singh S, O'Connor JP, Birge RB. Proapoptotic function of the nuclear CrkII adaptor protein. Biochemistry 2007; 46; 10828-10840.
26. Linghu H, Tsuda M, Makino Y et al. Involvement of adaptor protein Crk in malignant feature of human ovarian cancer cell line MCAS. Oncogene 2006; 25; 3547-3556.